Fluoxetine Opens Window to Improve Motor Recovery After Stroke (FLOW)
FLOW Trial: Fluoxetine to Open the Critical Period Time Window to Improve Motor Recovery After Stroke
Sponsor: Applied Health Research Centre
A PHASE2 clinical study on Brain Diseases and Brain Infarction, this trial is completed. The trial is conducted by Applied Health Research Centre and has accumulated 14 data snapshots since 2019. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.
Status Flow
Change History
14 versions recorded-
Sep 2024 — Present [monthly]
Completed PHASE2
-
Jul 2024 — Sep 2024 [monthly]
Completed PHASE2
-
Dec 2022 — Jul 2024 [monthly]
Completed PHASE2
Status: Active Not Recruiting → Completed
-
Jun 2022 — Dec 2022 [monthly]
Active Not Recruiting PHASE2
Status: Recruiting → Active Not Recruiting
-
Jan 2021 — Jun 2022 [monthly]
Recruiting PHASE2
▶ Show 9 earlier versions
-
Dec 2020 — Jan 2021 [monthly]
Recruiting PHASE2
-
Sep 2019 — Dec 2020 [monthly]
Recruiting PHASE2
-
Aug 2019 — Sep 2019 [monthly]
Recruiting PHASE2
-
Jul 2019 — Aug 2019 [monthly]
Recruiting PHASE2
-
Jun 2019 — Jul 2019 [monthly]
Recruiting PHASE2
-
Apr 2019 — Jun 2019 [monthly]
Recruiting PHASE2
Status: Not Yet Recruiting → Recruiting
-
Nov 2018 — Apr 2019 [monthly]
Not Yet Recruiting PHASE2
-
Jun 2018 — Nov 2018 [monthly]
Not Yet Recruiting PHASE2
-
Mar 2018 — Jun 2018 [monthly]
Not Yet Recruiting PHASE2
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- Applied Health Research Centre
- Brain Canada
- Dalhousie University
- Heart and Stroke Foundation Canadian Partnership for Stroke Recovery
- Memorial University of Newfoundland
- Parkwood Hospital, London, Ontario
- Riverview Health Centre Foundation
- Sunnybrook Health Sciences Centre
- University Health Network, Toronto
- University of British Columbia
- University of Calgary
For direct contact, visit the study record on ClinicalTrials.gov .